Pharmafile Logo

News and Press Releases

Closed Loop Medicine and Pharmanovia commence OptiZest study for their first precision medicine combination therapeutic

Proof-of-concept study to investigate personalised dose management of first-line anti-hypertensive in improving blood pressure control remotely Key milestone in co-development partnership to combine leading medicine brands with dose optimisation technology...

Category: Biotechnology, Clinical Trials
Posted: May 16, 2024

Closed Loop Medicine
info@closedloopmedicine.com
Babraham Research Campus Cambridge CB22 3AT United Kingdom

Closed Loop Medicine demonstrates application of novel drug plus software product for personalised treatment of hypertension

Study published in JAHA validates use of proprietary technology to identify personalised dose regimen, leading to improved blood pressure control and exceptionally high adherence in hypertension patients Findings will guide...

Category: Biotechnology
Posted: February 8, 2024

Closed Loop Medicine
info@closedloopmedicine.com
Babraham Research Campus Cambridge CB22 3AT United Kingdom

Closed Loop Medicine appoints Konstantinos Vlassis as Chief Technology Officer

Key executive leadership role will oversee design and implementation of technology strategy, engineering resources and infrastructure to deliver corporate objectives 10 October 2023 -- London, UK -- Closed Loop Medicine,...

Category: Biotechnology
Posted: October 10, 2023

Closed Loop Medicine
info@closedloopmedicine.com
Babraham Research Campus Cambridge CB22 3AT United Kingdom